COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Maryland patients with a documented clinical need may be eligible for compounded tirzepatide.
Maryland benefits from proximity to Washington, D.C., NIH, and Johns Hopkins, giving residents strong healthcare access. Compounding Finder helps Maryland patients compare licensed pharmacies statewide.
Yes. The Maryland Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.